| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate |
2012-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e58a1d24c7fd97c192daf2ff74f7c071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29fa1c0cb4446afe9f4ccb7cd1208dae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43d16b1a72e65f2fc80216b62969db4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bda00fdcd4335764f433d76371457b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acaffb2f445f522385c31893874d7e01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f09e4dfc59155f136a3cb8ca6b8874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_918a578181c63399cd4adcc9a2a17855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03d0ecd6168579193e36523fbe13503e |
| publicationDate |
2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2673277-A1 |
| titleOfInvention |
[1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase |
| abstract |
The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I). |
| priorityDate |
2011-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |